Search

everythinglearnresearchcommunity

for

Search:↓

Stem cell therapies show the most promise for anti-aging benefits.

PRP injections help with carpal tunnel symptoms short-term, but more research is needed for long-term effects.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

Alopecia areata negatively affects the self-esteem and quality of life of children and teens.

Reliable, non-invasive tools are needed for better vitiligo diagnosis.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Hair transplants can work for frontal fibrosing alopecia and lichen planopilaris, but results are less favorable and the conditions can develop after the transplant.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

Primary cicatricial alopecia significantly reduces life quality, mainly due to pain and anxiety.

Researchers should follow the FACE-Q User's Guide for accurate results.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

PRP treatment increases hair density and thickness in androgenetic alopecia by 79%.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Various treatments, including FDA-approved drugs, natural products, and oral supplements, can help with hair loss, but a patient's medical history and potential allergies should be considered when choosing a treatment.

Finasteride effectively reduces symptoms of enlarged prostate with minimal side effects.

Antihistamines may help with hair regrowth in alopecia areata, but dupilumab's effects are mixed.

There is a significant need for better-validated quality of life tools in dermatology.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Targeting psychosocial factors can help reduce self-stigma in people with chronic skin diseases.

COVID-19 patients may experience temporary hair loss, mainly in women, which is likely reversible.

Epidermal growth factor helps skin and hair regeneration but needs more research for better understanding.

Topical minoxidil significantly increases hair growth in androgenetic alopecia but only some patients see cosmetically acceptable results.

Most cutaneous adnexal tumors examined were benign and resembled common skin tumors.

PRP treatment improves hair density and diameter in women with androgenetic alopecia.

Combination therapies work better than single treatments for hair loss.

Testosterone replacement therapy, especially intramuscular, raises PSA levels, but no overall link between PSA and testosterone was found except in non-BPH patients.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

The study identified 12 potential biomarkers for hair loss and how they affect hair growth.